Table 1.
Bacterial Host | Temperate Phages | VGs/ARGs | Toxin/Antibiotic Resistance | Transduction Efficiency | Recipient | References |
---|---|---|---|---|---|---|
Escherichia coli | Stx1- and Stx2- converting phages | stx | Shiga toxin | 10−3 to 10−5 tru a/cell | Non-pathogenic Enterobacter and E. coli | [20,44,45] |
E. coli prophage | blaTEM, blaCTX-M | β-lactams | NA b | E. coli | [50] | |
Stx phages 933W, 557, 312, and Cdt phage | armA | Aminoglycosides | NA | E. coli | [51] | |
SUSP1, SUSP2 | kan, amp | Kanamycin, ampicillin | NA | E. coli, Bacillus sp., soil bacteria | [52] | |
Stx-converting prophage 933w | tet | Tetracycline | E. coli | [50,53] | ||
Salmonella | Fels-2, Enterobacteriaceae | oqxB_1, blaCTX-M | Quinolones, β-lactams | NA | NA | [54] |
ES18 | amp, tet, cam | Ampicillin, tetracycline, chloramphenicol | 10−8, 10−9, 10−7 tru/pfu c | S. Typhimurium | [55] | |
Vibrio cholerae | CTX𝜑 | ctxAB, zot | Cholera toxin, Zonula occludens toxin | NA | V. cholerae | [23,56] |
Campylobacter concisus | CON_phi2 | zot | Zonula occludens toxin | NA | C. concisus | [25,26] |
Clostridium perfringens | Clostridium phage phiMMP01, vbCpeS-CP51, PhiS63, Staphylococcus phage SP beta-like | cloSI, cpe, nanH, plc | α-toxins, Clostridium perfringens enterotoxin, sialidase, α-clostripain | NA | C. perfringens | [35] |
Staphylococcus aureus | 80α | TSST-1 | Shock toxin TSST-1 | 10−1 tru/pfu 10−1 to 10−6 tru/pfu |
S. aureus
L. monocytogenes |
[47] |
Staphylococcal phages | cat, aadDE, msrA | Chloramphenicol, aminoglycosides, macrolides | NA | S. aureus | [56] | |
80α | bla, tet | Penicillin, tetracycline | 10−5, 10−6 tru/pfu | S. aureus | [56,57] | |
PDT17 | amp, cam | Ampicillin, chloramphenicol | 10−8 tru/pfu | S. Typhimurium | [55] | |
Staphylococcal phages | bla, fusB | Penicillin, fusidic acid | NA | S. aureus | [56] | |
80α | str | Streptomycin | 10−1 tru/pfu | L. monocytogenes | [47] |
a Transduction unit. b No data available. c Plaque-forming units.